Literature DB >> 21103943

Predictors of oxidative stress in heart failure patients with Cheyne-Stokes respiration.

Ana C Krieger1, Daniel Green, Muriel T Cruz, Frank Modersitzki, Gita Yitta, Sanja Jelic, Doris S Tse, Steven P Sedlis.   

Abstract

PURPOSE: Cheyne-Stokes respiration during sleep is associated with increased mortality in heart failure. The magnitude of oxidative stress is a marker of disease severity and a valuable predictor of mortality in heart failure. Increased oxidative stress associated with periodic breathing during Cheyne-Stokes respiration may mediate increased mortality in these patients. We hypothesized that the presence of Cheyne-Stokes respiration is associated with oxidative stress by increasing the formation of reactive oxygen species in patients with heart failure. METHODS AND
RESULTS: Twenty-three patients with heart failure [left ventricular ejection fraction 30.2 ± 9% (mean ± standard deviation)] and 11 healthy controls underwent nocturnal polysomnography. Subjects with obstructive sleep apnea were excluded. The majority (88%) of patients with heart failure had Cheyne-Stokes respiration during sleep. The intensity of oxidative stress in neutrophils was greater in patients with heart failure (4,218 ± 1,706 mean fluorescence intensity/cell vs. 1,003 ± 348 for controls, p < 0.001) and correlated with the duration of Cheyne-Stokes respiration. Oxidative stress was negatively correlated with SaO(2) nadir during sleep (r = -0.43, p = 0.039). The duration of Cheyne-Stokes respiration predicted severity of oxidative stress in patients with heart failure (beta = 483 mean fluorescence intensity/cell, p < 0.02).
CONCLUSIONS: Levels of oxidative stress are increased in patients with heart failure and Cheyne-Stokes respiration during sleep compared with healthy controls. The duration of Cheyne-Stokes respiration predicts the magnitude of oxidative stress in heart failure. Increased oxidative stress may mediate increased mortality associated with Cheyne-Stokes respiration in patients with heart failure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21103943      PMCID: PMC5470639          DOI: 10.1007/s11325-010-0444-2

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  44 in total

Review 1.  Sleep apnea and heart failure: Part II: central sleep apnea.

Authors:  T Douglas Bradley; John S Floras
Journal:  Circulation       Date:  2003-04-08       Impact factor: 29.690

2.  Cardiac resynchronization therapy, central sleep apnea, and Cheyne-Stokes respiration in chronic heart failure patients.

Authors:  Christoph Scharf; Alexander Turk; Thomas Brack; Konrad Bloch
Journal:  J Am Coll Cardiol       Date:  2005-02-15       Impact factor: 24.094

3.  Increased oxidative stress in patients with congestive heart failure.

Authors:  M Keith; A Geranmayegan; M J Sole; R Kurian; A Robinson; A S Omran; K N Jeejeebhoy
Journal:  J Am Coll Cardiol       Date:  1998-05       Impact factor: 24.094

4.  Quantitative general theory for periodic breathing in chronic heart failure and its clinical implications.

Authors:  D P Francis; K Willson; L C Davies; A J Coats; M Piepoli
Journal:  Circulation       Date:  2000-10-31       Impact factor: 29.690

5.  Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure.

Authors:  P A Lanfranchi; A Braghiroli; E Bosimini; G Mazzuero; R Colombo; C F Donner; P Giannuzzi
Journal:  Circulation       Date:  1999-03-23       Impact factor: 29.690

6.  Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and interdependence.

Authors:  Ugo Corrà; Massimo Pistono; Alessandro Mezzani; Alberto Braghiroli; Andrea Giordano; Paola Lanfranchi; Enzo Bosimini; Marco Gnemmi; Pantaleo Giannuzzi
Journal:  Circulation       Date:  2005-12-27       Impact factor: 29.690

7.  The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure.

Authors:  G H Guyatt; M J Sullivan; P J Thompson; E L Fallen; S O Pugsley; D W Taylor; L B Berman
Journal:  Can Med Assoc J       Date:  1985-04-15       Impact factor: 8.262

8.  Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations.

Authors:  S Javaheri; T J Parker; J D Liming; W S Corbett; H Nishiyama; L Wexler; G A Roselle
Journal:  Circulation       Date:  1998-06-02       Impact factor: 29.690

9.  Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure.

Authors:  P J Hanly; N S Zuberi-Khokhar
Journal:  Am J Respir Crit Care Med       Date:  1996-01       Impact factor: 21.405

10.  NADPH oxidase contributes to coronary endothelial dysfunction in the failing heart.

Authors:  Ping Zhang; Mingxiao Hou; Yunfang Li; Xin Xu; Michel Barsoum; Yingjie Chen; Robert J Bache
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-23       Impact factor: 4.733

View more
  1 in total

1.  Short- and long-term effects of nocturnal oxygen therapy on sleep apnea in chronic heart failure.

Authors:  Philippe Bordier; Sebastien Orazio; Pauline Hofmann; Frederic Robert; Ghalia Bourenane
Journal:  Sleep Breath       Date:  2014-04-15       Impact factor: 2.816

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.